Rip Ballou, GSK Global Vaccines (EP.14) - a podcast by BioHealth Innovation, Inc. (BHI)

Rip Ballou, MD, VP & Head, GSK Global Vaccines US R&D Center and BHI President & CEO Rich Bendis discuss GSK’s move to the BioHealth Capital Region, their Vaccines Portfolio/Future, and the importance of succeeding in the industry today.

Further episodes of BioTalk with Rich Bendis

Further podcasts by BioHealth Innovation, Inc. (BHI)

Website of BioHealth Innovation, Inc. (BHI)